22nd Seminar of HITRIplus - Accelerators for Cancer Therapy: Emerging Trends and Future Perspectives

Tuesday 27 Jan 2026, 17:00 → 18:05 Europe/Zurich

ZOOM

Manjit Dosanjh (University of Oxford (GB)), Sandro Rossi (Fondazione CNAO)

Global general scientific seminars linked to the HITRIplus project activities organised in the context of WP2 Networking, Communication, and Dissemination.

To apply for beamtime, please follow the instructions on this page: https://hitriplus.eu/transnational-access/ 

---

   

About Maurizio Vretenar:

Maurizio Vretenar is an accelerator physicist who joined CERN in 1988, participating in the design, construction, and operation of linear accelerators. From 2008 to 2017, he was Project Leader for the construction of Linac4, the new 160 MeV linear injector for the CERN accelerator complex. Between 2013 and 2025, he coordinated a series of large EU-supported projects in joint particle accelerator R&D, including EuCARD-2, ARIES, and the innovation-oriented IFAST. In recent years, he has been increasingly active in societal applications of accelerators, particularly in the medical field, where he currently leads the Next Ion Medical Machine Study (NIMMS), a CERN initiative focused on accelerators for ion-based cancer therapy.

17:00 → 17:45 Accelerators for Cancer Therapy: Emerging Trends and Future Perspectives

Particle therapy is undergoing rapid evolution, driven by new clinical evidence, novel ion therapy projects, and strong expectations for innovative beam concepts—such as FLASH irradiation, targeted therapies, multiple and radioactive beams, new ion species, and microbeams—alongside a concerted push towards improved accessibility.

Behind these new concepts lie challenging demands on the performance of the accelerators producing the beams, coming in addition to the ongoing requirements for reduced footprint and cost. This seminar will focus on how future accelerators can meet these challenges and the technologies available to address them.

Speaker: Maurizio Vretenar (CERN)

17:45 → 18:00 Discussion